What changes are pharmacists in Indiana never allowed to make on a prescription for methylphenidate?

In Indiana, pharmacists are never allowed to make changes to certain critical elements of a prescription for methylphenidate, which is a controlled substance. This includes the patient's name, the controlled substance prescribed, and the prescriber's name or signature.

The patient's name is a key identifier and altering it would compromise the integrity of the prescription, potentially leading to legal and ethical issues. Additionally, modifying the controlled substance prescribed could result in the dispensing of an incorrect medication, which poses risks to patient safety and violates regulatory standards. The prescriber's name and signature are essential for verifying that the prescription is legitimately issued by a qualified healthcare provider, and any alteration here would undermine the authority of the prescription.

Because methylphenidate is classified as a Schedule II controlled substance, there are stringent regulations surrounding its prescription and dispensing to prevent misuse and ensure patient safety. Making unauthorized changes to any of these critical elements not only contravenes legal requirements but also puts the pharmacist at risk of disciplinary action. Therefore, option B correctly identifies the elements of a prescription for methylphenidate that pharmacists in Indiana are prohibited from modifying.